Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 49 for Inflammatory bowel disease (IBD)

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease

    Rochester, MN

  2. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

    Jacksonville, FL

  3. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)

    Jacksonville, FL

  4. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease

    La Crosse, WI

  5. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Subjects with Ulcerative Colitis

    Scottsdale/Phoenix, AZ

  6. Pharmacokinetics and Pharmacodynamic Biomarkers of Tofacitinib Therapy in Patients with Ulcerative Colitis (PROPHETIC Study)

    Rochester, MN

  7. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

    La Crosse, WI

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

    Rochester, MN

  9. A Study of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease

    Jacksonville, FL

  10. A Study of Oral Ozanimod as Maintenance Therapy for Moderately-to-Severely Active Crohn's Disease

    La Crosse, WI

.

Mayo Clinic Footer